Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J.L. Heerspink, Barry M. Brenner, Tom Greene et al.|The Lancet Diabetes & Endocrinology|2019Cited by 372